Comera Life Sciences Holdings, Inc. (CMRA)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -17.88 Million USD | -137.64% |
| 2021 | -5.36 Million USD | -175.3% |
| 2020 | -2.03 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | -2.47 Million USD | 17.19% |
| 2023 Q3 | -2.15 Million USD | -48.21% |
| 2023 Q2 | -1.45 Million USD | 41.13% |
| 2022 Q3 | -3.56 Million USD | 10.28% |
| 2022 Q2 | -3.97 Million USD | -39.18% |
| 2022 Q1 | -2.85 Million USD | -36.99% |
| 2022 FY | - USD | -137.64% |
| 2022 Q4 | -2.98 Million USD | 16.25% |
| 2021 Q4 | -2.08 Million USD | -132.94% |
| 2021 Q3 | -894.54 Thousand USD | 54.83% |
| 2021 Q2 | -1.98 Million USD | -194.96% |
| 2021 Q1 | -671.47 Thousand USD | 0.0% |
| 2021 FY | - USD | -175.3% |
| 2020 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| America Great Health | -447.29 Thousand USD | -3898.862% |
| Ampio Pharmaceuticals, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | 39.38% |
| Biora Therapeutics, Inc. | -114.05 Million USD | 84.317% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -13.486% |
| Better Therapeutics, Inc. | -38.26 Million USD | 53.252% |
| Calithera Biosciences, Inc. | -38.26 Million USD | 53.256% |
| Gene Biotherapeutics, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | 46.976% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | 46.404% |
| Evelo Biosciences, Inc. | -106.34 Million USD | 83.181% |
| Evolutionary Genomics, Inc. | -913.47 Thousand USD | -1858.086% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | 44.934% |
| Galera Therapeutics, Inc. | -46.69 Million USD | 61.692% |
| Innovation1 Biotech Inc. | -5.68 Million USD | -214.697% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -9.726% |
| Molecular Templates, Inc. | 1.43 Million USD | 1350.81% |
| Navidea Biopharmaceuticals, Inc. | -13.87 Million USD | -28.911% |
| NexImmune, Inc. | -28.16 Million USD | 36.499% |
| Orgenesis Inc. | -60.71 Million USD | 70.542% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | 65.129% |
| Point of Care Nano-Technology, Inc. | -73.41 Thousand USD | -24263.34% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -10.785% |
| Scopus BioPharma Inc. | -11.71 Million USD | -52.705% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 96.687% |
| Statera Biopharma, Inc. | 38.93 Million USD | 145.94% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -159.828% |
| Trevena, Inc. | -35.28 Million USD | 49.313% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -31811.277% |
| Vaccinex, Inc. | -19.74 Million USD | 9.426% |
| Vicapsys Life Sciences, Inc. | -1.04 Million USD | -1608.402% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | 61.831% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -146.27% |